Clinical Trials Browser

Phase 2 × Suspended × Doxorubicin × Clear all

NCT04803201 2026-04-02

Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma

Phase 2 Suspended

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

NCT03875144 2026-02-09

MESOTIP

Phase 2 Suspended

Peritoneal Neoplasms